Catalyst Wire Dossier Catalyst Wire Dossier

lacosamide (Vimpat)

lacosamide · UCB Pharma
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for lacosamide (Vimpat), covering 2011-07-15 to 2017-08-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Bioequivalence of Lacosamide 200mg Administered as Intravenous Solution and Oral Tablet in Healthy Chinese Male Subjects [Phase 1]

See pricing